Anthem Biosciences IPO listing was in line with the Street estimates as indicated by the grey market premium (GMP). Anthem ...

Anthem Biosciences Limited has made an initial public offering of equity shares aggregating to ₹3,395 crore. Trilegal ...

Key Details and Listing Information<br />The bidding for the Anthem Biosciences Initial Public Offering (IPO) took place from ...

Anthem Biosciences debuted on the stock market on July 21, listing at ₹723.05 on NSE, a 26.85% premium over its IPO price.

Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the IPO opening, ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% ...

Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Anthem Biosciences shares listed at ₹723.10 per share on the BSE and ₹723.05 per share on the NSE, compared to the issue ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...